FDA approves new psoriasis drug Taltz savita thakur thakur27 March 2016 9:34 AM ISTThe U.S. Food and Drug Administration approved Taltz (ixekizumab) to treat adults with moderate-to-severe plaque psoriasis.Psoriasis is a skin...
Gilead ordered to pay Merck $200 mln in hepatitis C drug patent dispute savita thakur thakur26 March 2016 4:26 PM ISTNew York : A federal jury on Thursday ordered Gilead Sciences Inc to pay Merck & Co $200 million in damages for infringing two Merck patents...
Sun Pharma and Astra Zeneca to promote Dapagliflozin for anti-diabetes Geeta Sharma Sharma26 March 2016 11:53 AM IST Mumbai: An Anti Diabetes drug Dapagliflozin under the brand name Oxra is being promoted by Sun pharma and Astra Zeneca. Oxra is another...
Cadila to host TB awareness programmes across the country Geeta Sharma Sharma26 March 2016 11:51 AM ISTNew Delhi: An All India Awareness Programme on Tuberculosis was initiated by Cadila Pharmaceutical companies in New Delhi two days ago.TB continues to...
Novartis settles with US over China bribe claims savita thakur thakur25 March 2016 12:10 PM ISTZurich: Swiss drugmaker Novartis said Thursday it had reached a deal with US authorities to pay $25 million (22.4 million euros) to settle claims that...
USFDA approves Teva's biotech drug for severe asthma savita thakur thakur25 March 2016 12:07 PM ISTThe U.S. Food and Drug Administration said on Wednesday it had approved Teva Pharmaceutical Industries Ltd's drug to treat asthma in adults who have a...
Frazier Healthcare raises $525 mln for healthcare fund savita thakur thakur25 March 2016 12:01 PM ISTPrivate-equity firm Frazier Healthcare Partners said on Wednesday it had raised $525 million to invest in small healthcare companies.The Seattle-based...
Portola's long-acting blood thinner misses main study goal savita thakur thakur25 March 2016 12:01 PM ISTNatalie Grover : Portola Pharmaceuticals Inc said data showed its oral anticoagulant missed the main goal of preventing blood clots in acutely ill...
UK cost agency says No to pricey Vertex cystic fibrosis drug savita thakur thakur25 March 2016 11:29 AM ISTLondon: A new cystic fibrosis treatment from Vertex Pharmaceuticals has been rejected as too expensive by Britain's healthcare cost agency NICE.The...
Eli Lilly drug for Psoriasis gets USFDA approval savita thakur thakur24 March 2016 9:58 AM ISTU.S. health regulators said on Tuesday they have approved a drug from Eli Lilly and Co to treat adults with moderate to severe cases of the skin...
200 new FDC applications sent back by NPPA Geeta Sharma Sharma24 March 2016 9:51 AM IST The National Pharmaceutical Pricing Authority (NPPA) has joined hands with the Health Minsitry to check irrational Fixed dose combinations (FDCs)....
Sanofi, Regeneron Praluent cholesterol study positive savita thakur thakur23 March 2016 4:38 PM ISTParis: French drugmaker Sanofi and U.S. partner Regeneron said a late-stage study of their Praluent injection showed it reduced the need for patients...
